학술논문
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial
Document Type
Article
Author
Janning, M.; Cubas-Cordova, M.; Gensch, V.; Ben-Batalla, I.; Bokemeyer, C.; Loges, S.; Pantel, K.; Müller, V.; Vettorazzi, E.; zu Eulenburg, C.; Schem, C.; Fasching, P.A.; Schnappauf, B.; Karn, T.; Fehm, T.; Just, M.; Kühn, T.; Holms, F.; Overkamp, F.; Krabisch, P.; Rack, B.; Denkert, C.; Untch, M.; Tesch, H.; Rezai, M.; Kittel, K.; Loibl, S.; von Minckwitz, G.
Source
In: International Journal of Cancer . (International Journal of Cancer, 1 August 2019, 145(3):857-868)
Subject
Language
English
ISSN
10970215
00207136
00207136